Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer.
Lin CY, Huang KY, Lin YC, Yang SC, Chung WC, Chang YL, Shih JY, Ho CC, Lin CA, Shih CC, Chang YH, Kao SH, Yang PC.
Lin CY, et al. Among authors: chung wc.
Cancer Lett. 2021 Jun 28;508:76-91. doi: 10.1016/j.canlet.2021.03.022. Epub 2021 Mar 26.
Cancer Lett. 2021.
PMID: 33775711